We are live on !
Find out more
Searle & Co Portfolio holdings
AUM
$419M
Turnover
8.54%
1-Year Est. Return
36.78%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+36.78%
3 Year Est. Return
+107.65%
5 Year Est. Return
+138.09%
10 Year Est. Return
+370.45%
AUM
$9.8M
AUM Growth
-$98.8M
(-91%)
Cap. Flow
-$99.3M
Cap. Flow % of AUM
Cap. Flow %
-1,008.46%
Top 10 Holdings %
Top 10 Hldgs %
67.16%
Holding
113
New
2
Increased
–
Reduced
20
Closed
89
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$198K |
| 2 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$169K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$5.37M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$4.19M |
| 3 |
Johnson & Johnson
JNJ
|
+$3.93M |
| 4 |
IBM
IBM
|
+$3.08M |
| 5 |
CVS Health
CVS
|
+$2.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 34.37% |
| 2 | Healthcare | 13.51% |
| 3 | Technology | 12.92% |
| 4 | Miscellaneous | 12.09% |
| 5 | Materials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
ExxonMobil
XOM
$675B
| $2.3M | 23.37% |
24,462
-60,690
| -71% | -$5.37M |
2014 Q4
6 quarters
|
|
2
Apple
AAPL
$5.08T
| $681K | 6.92% |
28,400
-29,252
| -51% | -$727K |
2014 Q4
6 quarters
|
|
|
MMP
3
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $672K | 6.83% |
9,000
-13,130
| -59% | -$931K |
2014 Q4
6 quarters
|
|
4
DELISTED
Du Pont De Nemours E I
DD
| $558K | 5.67% |
9,022
-8,006
| -47% | -$526K |
2014 Q4
6 quarters
|
|
5
Philip Morris
PM
$301B
| $526K | 5.34% |
5,132
-25,641
| -83% | -$2.56M |
2014 Q4
6 quarters
|
|
6
Revvity
RVTY
$17.9B
| $445K | 4.52% |
8,500
-19,300
| -69% | -$1.01M |
2014 Q4
6 quarters
|
|
7
Yum! Brands
YUM
$43.3B
| $434K | 4.41% |
7,186
-40,895
| -85% | -$2.41M |
2014 Q4
6 quarters
|
|
|
8
IBM
IBM
$234B
| $339K | 3.44% |
2,322
-21,546
| -90% | -$3.08M |
2014 Q4
6 quarters
|
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $331K | 3.36% |
1,400
-8,172
| -85% | -$1.88M |
2014 Q4
6 quarters
|
|
10
AbbVie
ABBV
$517B
| $324K | 3.29% |
5,100
-7,793
| -60% | -$475K |
2014 Q4
6 quarters
|
|
11
XPLR Infrastructure LP
XIFR
$691M
| $313K | 3.18% |
10,100
-48,100
| -83% | -$1.36M |
2014 Q4
6 quarters
|
|
12
Invesco QQQ Trust
QQQ
$460B
| $307K | 3.12% |
2,840
| – | – |
2015 Q4
2 quarters
|
|
13
Visa
V
$791B
| $304K | 3.09% |
4,100
-18,690
| -82% | -$1.46M |
2014 Q4
6 quarters
|
|
14
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $283K | 2.87% |
1,350
| – | – |
2015 Q4
2 quarters
|
|
|
15
DuPont de Nemours
DD
$20.4B
| $265K | 2.69% |
2,182
-7,007
| -76% | -$922K |
2014 Q4
6 quarters
|
|
16
Microsoft
MSFT
$4.04T
| $252K | 2.56% |
4,916
-28,780
| -85% | -$1.5M |
2014 Q4
6 quarters
|
|
17
iShares Select Dividend ETF
DVY
$23.7B
| $231K | 2.35% |
2,700
-1,100
| -29% | -$90.6K |
2015 Q4
2 quarters
|
|
18
Baxter International
BAX
$13.6B
| $230K | 2.34% |
5,000
-26,600
| -84% | -$1.17M |
2014 Q4
6 quarters
|
|
19
Mondelez International
MDLZ
$83.6B
| $221K | 2.25% |
4,884
-7,417
| -60% | -$323K |
2014 Q4
6 quarters
|
|
20
Chevron
CVX
$414B
| $210K | 2.13% |
2,000
-5,240
| -72% | -$527K |
2014 Q4
6 quarters
|
|
21
DELISTED
Hess
HES
| $200K | 2.03% |
3,500
-14,509
| -81% | -$840K |
2014 Q4
6 quarters
|
|
|
22
iShares Core S&P 500 ETF
IVV
$873B
| $200K | 2.03% |
+950
| New | +$198K |
2016 Q2
0 quarters
|
|
|
DNY
23
DELISTED
DONNELLEY R R & SONS CO
DNY
| $169K | 1.72% |
+10,100
| New | +$169K |
2016 Q2
0 quarters
|
|
|
AVP
24
DELISTED
Avon Products, Inc.
AVP
| $48K | 0.49% |
13,000
-5,000
| -28% | -$21.5K |
2014 Q4
6 quarters
|
|
25
Abbott
ABT
$191B
| – | – |
-10,479
| Closed | -$442K | – |
|
Similar funds
KFS
TM
NTCM
Searle & Co's Q2 2016 Portfolio in Review
As of Q2 2016, Searle & Co held 113 positions worth $9.8M, down 91% from $109M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Searle & Co withdrew a net $99.3M in Q2 2016, closing 89 positions and reducing 20 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $4.19M position sold in full.
By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Searle & Co opened a new position in iShares Core S&P 500 ETF worth $200K.
- Searle & Co's largest Q2 2016 buy was iShares Core S&P 500 ETF: 950 shares worth $200K.
- Searle & Co's biggest Q2 2016 reduction was ExxonMobil, cutting an estimated $5.37M.
- Searle & Co fully exited Bristol-Myers Squibb in Q2 2016, selling an estimated $4.19M.
- Searle & Co's ten largest holdings make up 67% of its $9.8M portfolio in Q2 2016.
- Searle & Co opened 2 new positions and closed 89 in Q2 2016.
- Searle & Co's portfolio value fell 91% quarter-over-quarter to $9.8M.
Based on Searle & Co's 13F filing for Q2 2016, filed 11 Jul 2016.